The EPA's War on Plants

The home gardening season is beginning in Northern California, and with it, a public-service campaign that asks, "Have you oversprayed your garden?" The runoff of agricultural chemicals--especially fertilizers, herbicides, and pesticides--directly into San Francisco Bay poses a perennial problem. What is not so obvious is that the U.S. Environmental Protection Agency is obstructing an innovative and environmentally friendly solution. The EPA's decision to introduce Draconian regulation of an e

Written byHenry Miller
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The home gardening season is beginning in Northern California, and with it, a public-service campaign that asks, "Have you oversprayed your garden?" The runoff of agricultural chemicals--especially fertilizers, herbicides, and pesticides--directly into San Francisco Bay poses a perennial problem. What is not so obvious is that the U.S. Environmental Protection Agency is obstructing an innovative and environmentally friendly solution.

The EPA's decision to introduce Draconian regulation of an entire class of negligible-risk crop and garden plants genetically improved with the new biotechnology has outraged the scientific community and virtually eliminated academic research and development in this sector. Building on a succession of antibiotechnology policies beginning in the mid-1980s, the EPA turned its sights several years ago on what was once one of biotechnology's most promising applications. The agency announced a policy in November 1994 that requires case-by-case regulatory review as pesticides of an entire category of products that had not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies